is compound tirzepatide fda approved The proposing the removal of three GLP-1 drugs from the 503B bulks list of active ingredients that outsourcing facilities can use to make compounded medicines, the agency announced on Thursday Did the FDA Ban Compounded

The Science of the GLP-1 "Super Responders" In the rapidly evolving landscape of weight loss medications, a new term has moved from clinical journals to viral social media: the "Super Responder." While medications like Wegovy and Zepbound are effective for the majority of users, a specific subset of patients experiences weight loss that far exceeds clinical averages

GLP-1s are not currently approved by the FDA for people with type 1 diabetes due to concerns around risks for hypoglycemia and diabetic ketoacidosis (DKA)

The risk is small, but still very real

Consequently, there is an urgent need for effective pharmacological interventions to address obesity and its associated health risks